Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANUH PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ANUH PHARMA   ACTAVIS
EQUITY SHARE DATA
    ANUH PHARMA
Mar-23
ACTAVIS
Dec-18
ANUH PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs11016,159-   
Low Rs7710,840-   
Sales per share (Unadj.) Rs105.33,963.8-  
Earnings per share (Unadj.) Rs7.2-1,276.8-  
Cash flow per share (Unadj.) Rs9.2417.7-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs48.116,349.0-  
Shares outstanding (eoy) m50.11332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.4 26.1%   
Avg P/E ratio x12.9-10.6 -122.4%  
P/CF ratio (eoy) x10.232.3 31.6%  
Price / Book Value ratio x1.90.8 235.1%  
Dividend payout %27.70-   
Avg Mkt Cap Rs m4,6834,489,898 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1720-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m5,2751,318,372 0.4%  
Other income Rs m6125,212 0.2%   
Total revenues Rs m5,3361,343,584 0.4%   
Gross profit Rs m51834,548 1.5%  
Depreciation Rs m97563,576 0.0%   
Interest Rs m776,078 0.0%   
Profit before tax Rs m475-579,893 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m113-7,349 -1.5%   
Profit after tax Rs m362-424,648 -0.1%  
Gross profit margin %9.82.6 374.8%  
Effective tax rate %23.81.3 1,876.9%   
Net profit margin %6.9-32.2 -21.3%  
BALANCE SHEET DATA
Current assets Rs m3,076540,727 0.6%   
Current liabilities Rs m1,613478,345 0.3%   
Net working cap to sales %27.74.7 586.1%  
Current ratio x1.91.1 168.7%  
Inventory Days Days6620 335.5%  
Debtors Days Days1,18566 1,786.8%  
Net fixed assets Rs m966149,232 0.6%   
Share capital Rs m2510-   
"Free" reserves Rs m2,1620-   
Net worth Rs m2,4125,437,670 0.0%   
Long term debt Rs m01,914,801 0.0%   
Total assets Rs m4,0428,500,316 0.0%  
Interest coverage x64.6-6.6 -976.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.2 841.4%   
Return on assets %9.1-4.1 -222.8%  
Return on equity %15.0-7.8 -192.1%  
Return on capital %20.0-4.8 -412.9%  
Exports to sales %52.50-   
Imports to sales %53.20-   
Net fx Rs m-380-   
CASH FLOW
From Operations Rs m539471,005 0.1%  
From Investments Rs m-435258,756 -0.2%  
From Financial Activity Rs m-123-808,385 0.0%  
Net Cashflow Rs m-19-78,232 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare ANUH PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ANUH PHARMA With: GLAND PHARMA  BERYL DRUGS  WYETH  DISHMAN CARBOGEN AMCIS  JUBILANT PHARMOVA   



Today's Market

Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5% Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5%(10:30 am)

Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.